Jennifer E. Bruin

Jennifer E. Bruin

Auto-generated profile, based on publicly available information

Jennifer E. Bruin

Carleton University

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2014 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ARAlireza Rezania
Alireza Rezania
JBJennifer E Bruin
Jennifer E Bruin
PAPayal Arora
Payal Arora
ARAllison Rubin
Allison Rubin
IBIrina Batushansky
Irina Batushansky
TKTimothy J Kieffer
Timothy J Kieffer

17 July 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
ARAlireza Rezania
Alireza Rezania
JBJennifer E. Bruin
Jennifer E. Bruin
MRMichael J. Riedel
Michael J. Riedel
MMMajid Mojibian
Majid Mojibian
AAAli Asadi
Ali Asadi
TKTimothy J. Kieffer
Timothy J. Kieffer
Diabetes is a chronic debilitating disease that results from insufficient production of insulin from pancreatic β-cells. Islet cell replacement can effectively treat diabetes but is currently severely limited by the reliance upon cadaveric donor tissue. We have developed a protocol to efficiently differentiate commercially available human embryonic stem cells (hESCs) in vitro into a highly enriched PDX1+ pancreatic progenitor cell population that further develops in vivo to mature pancreatic endocrine cells. Immature pancreatic precursor cells were transplanted into immunodeficient mice with streptozotocin-induced diabetes, and glycemia was initially controlled with exogenous insulin. As graft-derived insulin levels increased over time, diabetic mice were weaned from exogenous insulin and human C-peptide secretion was eventually regulated by meal and glucose challenges. Similar differentiation of pancreatic precursor cells was observed after transplant in immunodeficient rats. Throughout the in vivo maturation period hESC-derived endocrine cells exhibited gene and protein expression profiles that were remarkably similar to the developing human fetal pancreas. Our findings support the feasibility of using differentiated hESCs as an alternative to cadaveric islets for treating patients with diabetes.

2 April 2010 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
JBJennifer E. Bruin
Jennifer E. Bruin
HGHertzel C. Gerstein
Hertzel C. Gerstein
AHAlison Holloway
Alison Holloway
Cigarette smoking during pregnancy is associated with numerous obstetrical, fetal, and developmental complications, as well as an increased risk of adverse health consequences in the adult offspring. Nicotine replacement therapy (NRT) has been developed as a pharmacotherapy for smoking cessation and is considered to be a safer alternative for women to smoking during pregnancy. The safety of NRT use during pregnancy has been evaluated in a limited number of short-term human trials, but there is currently no information on the long-term effects of developmental nicotine exposure in humans. However, animal studies suggest that nicotine alone may be a key chemical responsible for many of the long-term effects associated with maternal cigarette smoking on the offspring, such as impaired fertility, type 2 diabetes, obesity, hypertension, neurobehavioral defects, and respiratory dysfunction. This review will examine the long-term effects of fetal and neonatal nicotine exposure on postnatal health.

29 July 2013 in Stem Cells
Verified
Journal Article
Open access
PDF file
ARAlireza Rezania
Alireza Rezania
JBJennifer E. Bruin
Jennifer E. Bruin
JXJean Xu
Jean Xu
KNKavitha Narayan
Kavitha Narayan
JFJessica K. Fox
Jessica K. Fox
TKTimothy J. Kieffer
Timothy J. Kieffer
Human embryonic stem cells (hESCs) are considered a potential alternative to cadaveric islets as a source of transplantable cells for treating patients with diabetes. We previously described a differentiation protocol to generate pancreatic progenitor cells from hESCs, composed of mainly pancreatic endoderm (PDX1/NKX6.1-positive), endocrine precursors (NKX2.2/synaptophysin-positive, hormone/NKX6.1-negative), and polyhormonal cells (insulin/glucagon-positive, NKX6.1-negative). However, the relative contributions of NKX6.1-negative versus NKX6.1-positive cell fractions to the maturation of functional β-cells remained unclear. To address this question, we generated two distinct pancreatic progenitor cell populations using modified differentiation protocols. Prior to transplant, both populations contained a high proportion of PDX1-expressing cells (∼85%–90%) but were distinguished by their relatively high (∼80%) or low (∼25%) expression of NKX6.1. NKX6.1-high and NKX6.1-low progenitor populations were transplanted subcutaneously within macroencapsulation devices into diabetic mice. Mice transplanted with NKX6.1-low cells remained hyperglycemic throughout the 5-month post-transplant period whereas diabetes was reversed in NKX6.1-high recipients within 3 months. Fasting human C-peptide levels were similar between groups throughout the study, but only NKX6.1-high grafts displayed robust meal-, glucose- and arginine-responsive insulin secretion as early as 3 months post-transplant. NKX6.1-low recipients displayed elevated fasting glucagon levels. Theracyte devices from both groups contained almost exclusively pancreatic endocrine tissue, but NKX6.1-high grafts contained a greater proportion of insulin-positive and somatostatin-positive cells, whereas NKX6.1-low grafts contained mainly glucagon-expressing cells. Insulin-positive cells in NKX6.1-high, but not NKX6.1-low grafts expressed nuclear MAFA. Collectively, this study demonstrates that a pancreatic endoderm-enriched population can mature into highly functional β-cells with only a minor contribution from the endocrine subpopulation. Stem Cells 2013;31:2432–2442

1 January 2016 in Cell Metabolism
Verified
Journal Article
Closed access
MSMarta Szabat
Marta Szabat
MPMelissa M. Page
Melissa M. Page
EPEvgeniy Panzhinskiy
Evgeniy Panzhinskiy
SSSøs Skovsø
Søs Skovsø
MMMajid Mojibian
Majid Mojibian
JJJames D. Johnson
James D. Johnson

16 June 2013 in Diabetologia
Verified
Journal Article
Closed access
PDF file
JBJennifer E. Bruin
Jennifer E. Bruin
ARAlireza Rezania
Alireza Rezania
JXJean Xu
Jean Xu
KNKavitha Narayan
Kavitha Narayan
JFJessica K. Fox
Jessica K. Fox
TKTimothy J. Kieffer
Timothy J. Kieffer